Status:
COMPLETED
A Study to Evaluate the Efficacy of a Counselling and Advisory Care for Health (COACH) Program in Dyslipidemic Patients.
Lead Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Conditions:
Dyslipidemia
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This study is a local PCO sponsored, interventional, non-drug study to evaluate the efficacy of a health tele-counselling program in reducing cardiovascular risk in dyslipidemic patients.
Detailed Description
Educational / Counseling
Eligibility Criteria
Inclusion
- Subjects who are newly diagnosed with dyslipidemias.
- Subjects must be lipid drug naive and eligible for statin therapy.
Exclusion
- Subjects who cannot be contacted by telephone or handphone.
- Subjects with uncontrolled primary hypothyroidism.
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
297 Patients enrolled
Trial Details
Trial ID
NCT00708370
Start Date
August 1 2008
End Date
June 1 2010
Last Update
February 18 2021
Active Locations (22)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Jitra, Kubang Pasu, Kedah, Malaysia, 06200
2
Pfizer Investigational Site
Kulim, Kedah, Malaysia, 09400
3
Pfizer Investigational Site
Sik, Kedah, Malaysia, 08200
4
Pfizer Investigational Site
Kubang Kerian, Kelantan, Malaysia, 16150